1-7 of 7
GEORGE F. GEILS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: Phase 2 Study of Subcutaneous Isatuximab, Administered By an on-Body Delivery System, in Combination with Weekly Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (SubQSA)

Tondre T. Buck, Clark Cutrer, Nashat Y. Gabrail, George F. Geils, Jr., Alexander Philipovskiy, Hayman S. Salib, Yvonne Barnes, Pamela Brill, Taro Fukao, Florence Leroy-Carita, Jesús G Berdeja
Journal: Blood
Blood (2024) 144 (Supplement 1): 4757.2.
https://doi.org/10.1182/blood-2024-203880
Published: 2024
Journal Articles

Treatment Initiation of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in Patients with Untreated Acute Myeloid Leukemia

Sudhir Manda, Bertrand Anz, III, Christopher Benton, E. Randolph Broun, Habte Yimer, John Renshaw, George F. Geils, Jr., Jose Cruz, Suzanne Fanning, Jason Melear, Jeff P. Sharman, Kingston Kang, Anders Svensson, Madhavi Pai, William Donnellan
Journal: Blood
Blood (2021) 138 (Supplement 1): 1265.
https://doi.org/10.1182/blood-2021-144886
Published: 2021
Journal Articles

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis of the Phase 3 Candor Study in Patients with Early or Late Relapse

Katja Weisel, MD, George F. Geils, MD, Lionel Karlin, MD, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Tae-Hoon Chung, Chang-Ki Min, MD PhD, Kazutaka Sunami, MD PhD, Amanda Goldrick, MD, Belle Fang, Jessica Fowler, PhD, Maria-Victoria Mateos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-133908
Published: 2020
Journal Articles

A Phase II Study of Pegylated Liposomal Doxorubicin, Bortezomib and Dexamethasone (DVD) for Patients with Previously Untreated Multiple Myeloma (MM).

James R. Berenson, MD, Ori Yellin, MD, Ravi Patel, MD, Chien-Shing Chen, MD, Ralph Vincent Boccia, MD, Donald Colbourn, MD, Honghao (Hank) Yang, MD, PhD, Varun Gupta, MD, George F. Geils, Jr., MD, Youram Nassir, MD, Jacqueline Hilger, MS, Regina A. Swift
Journal: Blood
Blood (2009) 114 (22): 4936.
https://doi.org/10.1182/blood.V114.22.4936.4936
Published: 2009
Journal Articles

Clinical Experience of Decitabine in Elderly Patients with Myelodysplastic Syndromes (MDS).

George F. Geils, Jr., MD
Journal: Blood
Blood (2009) 114 (22): 2792.
https://doi.org/10.1182/blood.V114.22.2792.2792
Published: 2009
Journal Articles

Enhanced Safety and Tolerability of Dose Intensive Pentostatin and Rituximab in Patients with CLL or Low-Grade B-Cell NHL.

Raul M. Mena, MD, Juliann Smith, MD, George F. Geils, MD, George F. Geils, Jr., MD, Furhan Yunus, MD, David W. Nyman, DO, Sebastian George, MD
Journal: Blood
Blood (2005) 106 (11): 937.
https://doi.org/10.1182/blood.V106.11.937.937
Published: 2005
Journal Articles

Treatment of Meningeal Leukemia With Pyrimethamine

GEORGE F. GEILS, M.D., CHARLIE W. SCOTT, JR., M.D., CHARLES M. BAUGH, PH.D., CHARLES E. BUTTERWORTH, JR., M.D.
Journal: Blood
Blood (1971) 38 (2): 131–137.
https://doi.org/10.1182/blood.V38.2.131.131
Published: 1971